HealthLynked Corp financial data

Symbol
HLYK on OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
Location
1265 Creekside Parkway, Suite 302, Naples, FL
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 50.5 % -9.14%
Quick Ratio 2.44 % -51.6%
Debt-to-equity -342 % -234%
Return On Equity 466 %
Return On Assets -193 % -899%
Operating Margin -155 % -114%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 282M shares +0.31%
Common Stock, Shares, Outstanding 282M shares +2.17%
Entity Public Float 14.3M USD +19.4%
Common Stock, Value, Issued 28.2K USD +2.17%
Weighted Average Number of Shares Outstanding, Basic 282M shares +7.1%
Weighted Average Number of Shares Outstanding, Diluted 282M shares +7.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.01M USD -47.4%
Revenue from Contract with Customer, Excluding Assessed Tax 16.3K USD
Operating Income (Loss) -4.68M USD -12.7%
Nonoperating Income (Expense) -1.45M USD -370%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.13M USD -69.7%
Net Income (Loss) Attributable to Parent -6.13M USD -506%
Earnings Per Share, Basic -0.02 USD/shares
Earnings Per Share, Diluted -0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 76.2K USD -69.2%
Accounts Receivable, after Allowance for Credit Loss, Current 25.6K USD -38.5%
Inventory, Net 44.7K USD -66.5%
Other Assets, Current 101K USD -4.18%
Assets, Current 1.64M USD +150%
Property, Plant and Equipment, Net 177K USD -39.3%
Operating Lease, Right-of-Use Asset 361K USD -61.4%
Goodwill 320K USD -78.4%
Assets 2.22M USD -48.1%
Accrued Liabilities, Current 90.5K USD -0.85%
Contract with Customer, Liability, Current 233K USD -14.4%
Liabilities, Current 4.69M USD +94.4%
Operating Lease, Liability, Noncurrent 154K USD -75%
Liabilities 5.35M USD +54%
Retained Earnings (Accumulated Deficit) -48.2M USD -14.6%
Stockholders' Equity Attributable to Parent -3.13M USD -489%
Liabilities and Equity 2.22M USD -48.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -855K USD +22.3%
Net Cash Provided by (Used in) Financing Activities 634K USD +95%
Net Cash Provided by (Used in) Investing Activities -2.6K USD -100%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 282M shares +2.17%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.78K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76.2K USD -69.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6.58K USD +101%
Deferred Tax Assets, Valuation Allowance 9.85M USD +10.6%
Operating Lease, Liability 362K USD -61.5%
Depreciation 115K USD -7.08%
Payments to Acquire Property, Plant, and Equipment 2.6K USD
Lessee, Operating Lease, Liability, to be Paid 917K USD +36.3%
Property, Plant and Equipment, Gross 811K USD -0.05%
Operating Lease, Liability, Current 209K USD -36%
Lessee, Operating Lease, Liability, to be Paid, Year Two 329K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 453K USD +71.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.35 pure +124%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 236K USD +57.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 989 USD -99.5%
Deferred Tax Assets, Operating Loss Carryforwards 10.2M USD +12.9%
Preferred Stock, Shares Issued 2.75M shares
Preferred Stock, Shares Authorized 20M shares
Unrecognized Tax Benefits 653 USD -97.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 990 USD
Additional Paid in Capital 44.8M USD +5.45%
Preferred Stock, Shares Outstanding 2.75M shares
Amortization of Intangible Assets 168K USD -26.4%
Depreciation, Depletion and Amortization 86.5K USD -1.78%
Interest Expense 39.1K USD +772%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares